Metastron Articles
Amersham gets rights to Bexxar in Europe
31 October 2001
Corixa and Nycomed co-promote Metastron
18 July 2001
Amersham Pharmacia Biotech Unveiled
11 June 1997
Currency, Life Sciences Boost Amersham Results
17 June 1996
Improving Fundamentals At Amersham Int'l
22 April 1996
Amersham's Myoview Gets FDA Go-Ahead
19 February 1996
Amersham Looks Forward To The Future
13 November 1995
Amersham's Growth Slows To 9%
12 June 1995
Amersham's 1st Half Disappoints But Strategy Good
14 November 1994
AMERSHAM'S GOOD RESULTS BOOSTED BY USB
13 June 1994
MEDI-PHYSICS LAUNCH
23 May 1994
METASTRON HAILED AS MAJOR ADVANCE
7 February 1994
HALF-YEAR PROFITS UP 71% AT AMERSHAM
15 November 1993
PENDING APPLICATIONS IN US CONTINUE TO DWINDLE
19 July 1993
EUROPEAN STOCK COMMENT
28 June 1993
AMERSHAM'S METASTRON APPROVED IN USA
28 June 1993
AMERSHAM INT'L FOCUSSED AND GROWING
21 June 1993
METASTRON REVIEWED
31 May 1993
ZENECA TO PROMOTE METASTRON
5 April 1993
Showing 1-19 of 19 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
